Fan Wang Selected Research

cyclic arginine-glycine-aspartic acid peptide

1/2016	Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging.
1/2011	Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability.
2/2010	Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.
11/2009	99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.
8/2009	2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.
6/2009	(68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging.
1/2009	Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
3/2007	Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fan Wang Research Topics

Disease

254	Neoplasms (Cancer) 12/2022 - 03/2003
39	Inflammation (Inflammations) 01/2022 - 09/2010
38	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 07/2005
37	Neoplasm Metastasis (Metastasis) 11/2021 - 12/2003
35	Breast Neoplasms (Breast Cancer) 02/2022 - 03/2007
30	Glioma (Gliomas) 12/2021 - 07/2006
27	Infections 01/2022 - 11/2008
23	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 08/2008
18	Pancreatic Neoplasms (Pancreatic Cancer) 02/2022 - 05/2012
17	Hypoxia (Hypoxemia) 05/2022 - 05/2010
17	Carcinogenesis 02/2022 - 01/2014
16	Body Weight (Weight, Body) 07/2022 - 02/2004
15	Nasopharyngeal Carcinoma 06/2022 - 06/2005
15	Fibrosis (Cirrhosis) 01/2021 - 01/2011
14	Carcinoma (Carcinomatosis) 01/2020 - 06/2008
13	Wounds and Injuries (Trauma) 06/2022 - 05/2004
13	Schizophrenia (Dementia Praecox) 04/2022 - 07/2008
13	Pain (Aches) 03/2021 - 10/2011
12	Necrosis 06/2022 - 02/2004
12	COVID-19 01/2022 - 01/2020
12	Lung Neoplasms (Lung Cancer) 01/2022 - 12/2003
12	Reperfusion Injury 01/2021 - 01/2013
12	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 08/2010
11	Hypertension (High Blood Pressure) 10/2022 - 03/2010
11	Ischemia 01/2019 - 01/2013
11	Colonic Neoplasms (Colon Cancer) 01/2019 - 06/2008
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2015
10	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 05/2009
9	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2010
9	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 01/2016
9	Adenocarcinoma of Lung 01/2022 - 01/2016
8	Alcoholism (Alcohol Abuse) 01/2022 - 08/2012
8	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 09/2010
8	Cerebral Hemorrhage 10/2019 - 04/2011
8	Hepatitis 01/2018 - 01/2013
7	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2018
7	Obesity 01/2021 - 12/2008
7	Brain Neoplasms (Brain Tumor) 01/2020 - 05/2008
7	Autoimmune Hepatitis 01/2018 - 01/2013
7	Hematoma 04/2017 - 08/2011
6	Brain Injuries (Brain Injury) 03/2022 - 01/2013
6	Adult-Onset Still's Disease 01/2022 - 01/2019
6	Heroin Dependence (Heroin Abuse) 01/2022 - 05/2016
6	Squamous Cell Carcinoma of Head and Neck 01/2022 - 09/2010

Drug/Important Bio-Agent (IBA)

60	Biomarkers (Surrogate Marker)IBA 04/2022 - 06/2013
53	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2008
48	Peptides (Polypeptides)IBA 01/2022 - 03/2007
46	Pharmaceutical PreparationsIBA 05/2022 - 10/2006
45	IntegrinsIBA 01/2021 - 03/2007
31	MicroRNAs (MicroRNA)IBA 03/2022 - 01/2012
24	CytokinesIBA 01/2021 - 07/2008
22	Biological ProductsIBA 04/2022 - 04/2011
22	Long Noncoding RNAIBA 02/2022 - 05/2016
20	Messenger RNA (mRNA)IBA 01/2022 - 01/2010
14	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 02/2013
13	EnzymesIBA 10/2022 - 03/2003
13	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2011
13	Monoclonal AntibodiesIBA 01/2022 - 12/2003
13	AntioxidantsIBA 01/2022 - 08/2008
13	Integrin alphaVbeta3IBA 02/2010 - 07/2006
12	Interleukin-6 (Interleukin 6)IBA 01/2021 - 12/2008
10	AcidsIBA 04/2022 - 07/2006
10	Therapeutic UsesIBA 11/2021 - 11/2005
10	Transcription Factors (Transcription Factor)IBA 10/2020 - 01/2011
10	Concanavalin AIBA 07/2018 - 01/2013
10	ErbB Receptors (EGF Receptor)IBA 06/2018 - 10/2006
9	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2022 - 01/2012
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 12/2008
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2021 - 03/2007
9	Bombesin Receptors (Bombesin Receptor)IBA 10/2013 - 06/2008
9	arginyl-glycyl-aspartic acidIBA 04/2011 - 07/2006
8	CateninsIBA 01/2022 - 01/2013
8	LipidsIBA 08/2021 - 11/2014
8	Fluorouracil (Carac)FDA LinkGeneric 05/2021 - 01/2014
8	LipopolysaccharidesIBA 01/2020 - 01/2016
8	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019 - 01/2011
8	cyclic arginine-glycine-aspartic acid peptideIBA 01/2016 - 03/2007
8	BombesinIBA 10/2013 - 01/2009
7	Oxygen (Dioxygen)IBA 03/2022 - 05/2010
7	LigandsIBA 01/2022 - 03/2007
7	Radioisotopes (Radionuclides)IBA 01/2022 - 05/2009
7	Small Interfering RNA (siRNA)IBA 01/2021 - 09/2018
7	oxidized low density lipoproteinIBA 01/2021 - 03/2010
7	RNA (Ribonucleic Acid)IBA 10/2020 - 06/2008
7	Interleukin-2 (IL2)IBA 04/2020 - 05/2009
7	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 10/2009
7	Antipsychotic Agents (Antipsychotics)IBA 02/2016 - 12/2008
7	tricineIBA 10/2013 - 07/2006
6	ImmunosorbentsIBA 06/2022 - 05/2014
6	Immunoglobulin G (IgG)IBA 03/2022 - 09/2008
6	HemocyaninsIBA 01/2022 - 09/2016

Therapy/Procedure

132	Therapeutics 08/2022 - 01/2008
40	Drug Therapy (Chemotherapy) 01/2022 - 05/2010
24	Radiotherapy 01/2021 - 06/2010
11	Aftercare (After-Treatment) 11/2020 - 08/2003
9	Immunotherapy 08/2021 - 03/2014
9	Precision Medicine 05/2020 - 01/2011
9	Transplantation 01/2019 - 01/2009
8	Lasers (Laser) 05/2021 - 10/2015
6	Photothermal Therapy 01/2022 - 11/2016